ArticleCancer medicine2019

Pharmacovigilance evaluation of the relationship between impaired glucose metabolism and BCR-ABL inhibitor use by using an adverse drug event reporting database.

Naoto Okada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.